NeurosciencebioRxivPreprint
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALS
Defne A. Amado, Ashley B. Robbins, Alicia R. Smith…·Beverly L. Davidson
7 citations